Edition:
United Kingdom

People: Kalvista Pharmaceuticals Inc (KALV.OQ)

KALV.OQ on NASDAQ Stock Exchange Global Market

25.82USD
6:04pm BST
Change (% chg)

$0.32 (+1.25%)
Prev Close
$25.50
Open
$25.51
Day's High
$25.92
Day's Low
$25.51
Volume
7,937
Avg. Vol
24,574
52-wk High
$34.65
52-wk Low
$7.74

Crockett, Thomas 

Mr. Thomas Andrew Crockett is Chief Executive Officer and Director of the Company. He has served as a member of our Board and as our Chief Executive Officer since November 2016 and as a director and CEO of our wholly owned subsidiary, KalVista Pharmaceuticals Limited, since inception in 2011. From 2010 until November 2015, Mr. Crockett was the Chief Executive Officer and member of the board of directors of Vantia Ltd., where he served as Vice President of Business Development prior to his promotion. He continues to sit on the board of directors. Mr. Crockett has also held various senior management positions including Vice President of Business Development and Director of Clinical and Regulatory Affairs in biotech and specialty pharmaceutical companies in the United States and United Kingdom. Mr. Crockett received a B.A. from the University of Utah and M.B.A. from The Wharton School, University of Pennsylvania, with a major in finance.

Basic Compensation

Total Annual Compensation, USD 1,125,000
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 917,276
Fiscal Year Total, USD 2,042,280

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --